HR 3616 · 109th Congress · Health
Inflammatory Bowel Disease Research Act
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Sponsor introductory remarks on measure. (CR E2334)(2005-11-10)
Plain Language Summary
[AI summary unavailable — showing source text]
Inflammatory Bowel Disease Research Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand, intensify, and coordinate the Institute's research activities on inflammatory bowel disease, with an emphasis on: (1) genetic research on susceptibility for inflammatory bowel disease; (2) research targeted to increase knowledge about the causes and complications of inflammatory bowel disease in children; (3) animal model research; (4) clinical research; (5) expansion of the Institute's Inflammatory Bowel Disease Centers program with a focus on pediatric research; and (6) other research initiatives identified in specified documents. Requires the Director of the Centers for Disease Control and Prevention (CDC) to prepare a National Inflammatory Bowel Disease Action Plan to: (1) address the burden of inflammatory bowel disease in both adult and pediatric populations; (2) address strategies for determining the prevalence of the disease in the United States and the unique demographic characteristics of the patient community; (3) focus on strategies for increasing awareness about the disease within the general public and the health care commu…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (20)
16 Democrats4 Republicans